Use of subcutaneous tocilizumab in patients with COVID-19 pneumonia

J Med Virol. 2021 Jan;93(1):32-34. doi: 10.1002/jmv.26016. Epub 2020 Sep 30.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • COVID-19 Drug Treatment*
  • Humans
  • Off-Label Use
  • SARS-CoV-2*

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab